Cargando…

QTc Dynamics Following Cardioversion for Persistent Atrial Fibrillation

BACKGROUND: Cardioversion (CV) for atrial fibrillation (AF) is common. We aimed to assess changes in QTc over time following electrical CV (ECV) for persistent AF, and to compare the benefit of using continuous Holter monitoring vs. conventional follow-up by ECG. METHODS: Prospective observational c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Younis, Arwa, Nehoray, Nofrat, Glikson, Michael, Bodurian, Christopher, Nof, Eyal, Bragazzi, Nicola Luigi, Berger, Michael, Zareba, Wojciech, Goldenberg, Ilan, Beinart, Roy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205203/ https://www.ncbi.nlm.nih.gov/pubmed/35722129 http://dx.doi.org/10.3389/fcvm.2022.881446

Ejemplares similares

Ethnic Disparity in Mortality Among Ischemic Heart Disease Patients. A-20 Years Outcome Study From Israel
por: Abu-Much, Arsalan, et al.
Publicado: (2021)

Transvenous lead extraction with laser reduces need for femoral approach during the procedure
por: Younis, Arwa, et al.
Publicado: (2019)

Comparison of clinical outcomes of Ibutilide-guided cardioversion and direct current synchronized cardioversion after radiofrequency ablation of persistent atrial fibrillation
por: Liu, Xing, et al.
Publicado: (2023)

Occluded vein as a predictor for complications in non-infectious transvenous lead extraction
por: Milman, Anat, et al.
Publicado: (2022)

Left Atrial Appendage Occlusion versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation—One-Year Survival
por: Tiosano, Shmuel, et al.
Publicado: (2023)

Subclinical postoperative atrial fibrillation: a randomized trial
por: Sabbag, Avi, et al.
Publicado: (2023)

Genetic variant annotation scores in congenital long QT syndrome
por: Younis, Arwa, et al.
Publicado: (2023)

Primary prevention implantable cardioverter defibrillator in cardiac resynchronization therapy recipients with advanced chronic kidney disease
por: Goldenberg, Ido, et al.
Publicado: (2023)

Defining the benefit: Cardioversion of persistent atrial fibrillation
por: Nedios, Sotirios, et al.
Publicado: (2021)

Early de-cannulation from extracorporeal membrane oxygenation following ventricular tachycardia radiofrequency ablation
por: Sabbag, Avi, et al.
Publicado: (2022)

The efficacy of the Linox(Smart) DX ICD lead from a single center experience
por: Marai, Ibrahim, et al.
Publicado: (2019)

Risk factors for ventricular tachyarrhythmic events in patients without left bundle branch block who receive cardiac resynchronization therapy
por: Younis, Arwa, et al.
Publicado: (2021)

QT prolongation-related ventricular arrhythmia associated with atrial fibrillation electrical cardioversion
por: Rav Acha, M, et al.
Publicado: (2023)

Mutations in Na(V)1.5 Reveal Calcium-Calmodulin Regulation of Sodium Channel
por: Nof, Eyal, et al.
Publicado: (2019)

Feasibility and safety of the direct current cardioversion at the time of left atrial appendage occlusion for patients with atrial fibrillation
por: Meng, Xian Sai, et al.
Publicado: (2023)

Internal cardioversion of persistent atrial fibrillation in implantable cardioverter defibrillator patients: the juice is not worth the squeeze
por: Berger, W. R., et al.
Publicado: (2013)

CHA(2)DS(2)‐VASc Score and the Risk of Ventricular Tachyarrhythmic Events and Mortality in MADIT‐CRT
por: Nof, Eyal, et al.
Publicado: (2019)

Effect of Early Pharmacologic Cardioversion vs. Non-early Cardioversion in the Patients With Recent-Onset Atrial Fibrillation Within 4-Week Follow-Up Period: A Systematic Review and Network Meta-Analysis
por: Tang, Yan, et al.
Publicado: (2022)

Programmed inappropriate ICD ventricular defibrillation for cardioversion of persistent atrial fibrillation
por: Korantzopoulos, Panagiotis, et al.
Publicado: (2008)

Low efficacy of cardioversion of persistent atrial fibrillation with the implantable cardioverter-defibrillator
por: Limantoro, I., et al.
Publicado: (2013)

Frequency of cardioversions as an additional risk factor for stroke in atrial fibrillation – the FinCV-4 study
por: Jaakkola, Samuli, et al.
Publicado: (2022)

Andersen–Tawil Syndrome Is Associated With Impaired PIP(2) Regulation of the Potassium Channel Kir2.1
por: Handklo-Jamal, Reem, et al.
Publicado: (2020)

Pharmacological Cardioversion after Pre-Treatment with Antiarrythmic Drugs Prior to Electrical Cardioversion in Persistent Atrial Fibrillation: Impact on Maintenance of Sinus Rhythm
por: El Amrani, Amine, et al.
Publicado: (2021)

The clinical outcomes of patients who developed typical atrial flutter on class 1C anti arrhythmic medications treated with hybrid approach
por: Grossman, Lior, et al.
Publicado: (2019)

Inducibility of Multiple Ventricular Tachycardia’s during a Successful Ablation Procedure Is a Marker of Ventricular Tachycardia Recurrence
por: Nissan, Johnatan, et al.
Publicado: (2023)

Biomarkers of Atrial Fibrillation Recurrence in Patients with Paroxysmal or Persistent Atrial Fibrillation Following External Direct Current Electrical Cardioversion
por: Demirel, Ozan, et al.
Publicado: (2023)

Advanced interatrial block predicts ineffective cardioversion of atrial fibrillation: a FinCV2 cohort study
por: Relander, Arto, et al.
Publicado: (2021)

Pharmacological cardioversion for atrial fibrillation and flutter
por: Cordina, J, et al.
Publicado: (2006)

Atrial fibrillation cardioversion following acupuncture
por: Dilber, Dario, et al.
Publicado: (2015)

Rivaroxaban in atrial fibrillation cardioversion: an update
por: Lavalle, Carlo, et al.
Publicado: (2019)

How to Optimize Cardioversion of Atrial Fibrillation
por: Airaksinen, K. E. Juhani
Publicado: (2022)

External Electrical Cardioversion is an Easy and Safe Intervention for Rhythm Control in Persistent Atrial Fibrillation
por: Kwon, Chang Hee
Publicado: (2020)

Effectiveness of electrical cardioversion for persistent atrial fibrillation in the ongoing protocolenergy: hawthorne effect trial
por: Jiravsky, O, et al.
Publicado: (2023)

Machine Learning Prediction for the Recurrence After Electrical Cardioversion of Patients With Persistent Atrial Fibrillation
por: Kwon, Soonil, et al.
Publicado: (2023)

A Cardioversion and Renal Dysfunction Cascade: Cardioversion for Atrial Fibrillation, Acute Kidney Injury, and Recurrence of Atrial Fibrillation
por: Asemota, Iriagbonse R, et al.
Publicado: (2020)

The Impact of Right Atrial Size to Predict Success of Direct Current Cardioversion in Patients With Persistent Atrial Fibrillation
por: Döring, Christoph, et al.
Publicado: (2023)

Pharmacological Cardioversion With Antazoline in Atrial Fibrillation: The Results of the CANT Study
por: Wybraniec, Maciej T., et al.
Publicado: (2018)

Confirm Rx insertable cardiac monitor for primary atrial fibrillation detection in high‐risk heart failure patients (Confirm‐AF trial)
por: Aktas, Mehmet K., et al.
Publicado: (2022)

Racial and Sex Disparities in Anticoagulation After Electrical Cardioversion for Atrial Fibrillation and Flutter
por: Mentias, Amgad, et al.
Publicado: (2021)

Prediction of Successful Pharmacological Cardioversion in Acute Symptomatic Atrial Fibrillation: The Successful Intravenous Cardioversion for Atrial Fibrillation (SIC-AF) Score
por: Niederdöckl, Jan Daniel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ksj4uklrk2fedlmadorvagsg14